X.T.L. Biopharmaceuticals Overview

X.T.L. Biopharmaceuticals Operating Income

Operating Income for XTLB.

Quarterly Operating Income

$-812000.00

↑ 306% YoY

As of Dec 31, 2024

Annual Operating Income (TTM)

$-2172000.00

↑ 183.92% YoY

Trailing 12 months ending Dec 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin